4//SEC Filing
Chen Hongming 4
Accession 0001179110-20-004335
CIK 0001479419other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:43 PM ET
Size
6.5 KB
Accession
0001179110-20-004335
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-03-30−31,000→ 75,236 totalExercise: $2.30Exp: 2024-10-01→ Common Stock (31,000 underlying) - Exercise/Conversion
Common Stock
2020-03-30$2.30/sh+31,000$71,300→ 86,849 total
Footnotes (1)
- [F1]The option became fully vested on July 21, 2018.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710697
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:43 PM ET
- Size
- 6.5 KB